alpha-aminopyridine has been researched along with Lymphoma, Large-Cell, Anaplastic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajciova, V; Jezova, M; Kanderova, V; Krenova, Z; Kyr, M; Lakka Klement, G; Merta, T; Mudry, P; Noskova, K; Palova, H; Pokorna, P; Slaby, O; Sterba, J; Valik, D; Vasikova, A; Zdrazilova Dubska, L | 1 |
| Ceccon, M; Chiriano, G; Gambacorti-Passerini, C; Mologni, L; Piazza, R; Pirola, A; Scapozza, L | 1 |
| Dong, M; Fan, Y; Feng, J; Hong, X; Huang, H; Ke, X; Li, W; Lu, X; Ning, Z; Qi, J; Shen, Z; Shi, Y; Yu, L; Zhang, W; Zhao, X; Zhou, D; Zhu, J | 1 |
| Barth, S; Beckett, RP; Davies, SJ; Engert, A; Foelster-Holst, R; Hansen, HP; Kisseleva, T; Lange, HH; Lemke, H; Matthey, B; Mokros, T | 1 |
1 trial(s) available for alpha-aminopyridine and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.
Topics: Adult; Aged; Aminopyridines; Antineoplastic Agents; Benzamides; Disease-Free Survival; Enteropathy-Associated T-Cell Lymphoma; Female; Histone Deacetylase Inhibitors; Humans; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mycosis Fungoides; Neoplasm Recurrence, Local; Neutropenia; Skin Neoplasms; Thrombocytopenia; Treatment Outcome; Young Adult | 2015 |
3 other study(ies) available for alpha-aminopyridine and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing.
Topics: Aminopyridines; Humans; Lactams; Lactams, Macrocyclic; Lymphoma, Large-Cell, Anaplastic; Neoplasm, Residual; Pyrazoles | 2022 |
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922.
Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Animals; Apoptosis; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetulus; Humans; Lactams; Lactams, Macrocyclic; Lymphoma, Large-Cell, Anaplastic; Models, Molecular; Mutation; Nuclear Proteins; Nucleophosmin; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Receptor Protein-Tyrosine Kinases; Signal Transduction; Sulfones; Triazines | 2015 |
Inhibition of metalloproteinases enhances the internalization of anti-CD30 antibody Ki-3 and the cytotoxic activity of Ki-3 immunotoxin.
Topics: Aminopyridines; Antibodies, Monoclonal; Cell Survival; Dose-Response Relationship, Drug; Endocytosis; Humans; Hydroxamic Acids; Immunotoxins; Ki-1 Antigen; Kinetics; Lymphoma; Lymphoma, Large-Cell, Anaplastic; Metalloendopeptidases; Protease Inhibitors; Tumor Cells, Cultured | 2002 |